NKT cells, Treg, and their interactions in bone marrow transplantation

Holbrook E. Kohrt, Asha Pillai, Robert Lowsky, Samuel Strober

Research output: Contribution to journalReview article

54 Citations (Scopus)

Abstract

Bone marrow transplantation (BMT) is a potentially curative treatment for patients with leukemia and lymphoma. Tumor eradication is promoted by the anti-tumor activity of donor T cells contained in the transplant; however, donor T cells also mediate the serious side effect of graft-versus-host disease (GVHD). Separation of GVHD from graft anti-tumor activity is an important goal of research in improving transplant outcome. One approach is to take advantage of the immunomodulatory activity of regulatory NKT cells and CD4+ CD25+ Treg of host and/or donor origin. Both host and donor NKT cells and donor Treg are able to prevent GVHD in murine models. In this review, we summarize the mechanisms of NKT cell- and Treg-mediated protection against GVHD in mice while maintaining graft anti-tumor activity. In addition, we also examine the interactions between NKT cells and Treg in the context of BMT, and integrate the data from murine experimental models with the observations made in humans.

Original languageEnglish (US)
Pages (from-to)1862-1869
Number of pages8
JournalEuropean Journal of Immunology
Volume40
Issue number7
DOIs
StatePublished - Jan 1 2010
Externally publishedYes

Fingerprint

Natural Killer T-Cells
Bone Marrow Transplantation
Graft vs Host Disease
Tissue Donors
Transplants
Neoplasms
T-Lymphocytes
Lymphoma
Leukemia
Theoretical Models
Research

Keywords

  • Bone marrow transplantation
  • Natural killer T cells
  • Regulatory T cells

ASJC Scopus subject areas

  • Immunology
  • Immunology and Allergy
  • Medicine(all)

Cite this

NKT cells, Treg, and their interactions in bone marrow transplantation. / Kohrt, Holbrook E.; Pillai, Asha; Lowsky, Robert; Strober, Samuel.

In: European Journal of Immunology, Vol. 40, No. 7, 01.01.2010, p. 1862-1869.

Research output: Contribution to journalReview article

Kohrt, Holbrook E. ; Pillai, Asha ; Lowsky, Robert ; Strober, Samuel. / NKT cells, Treg, and their interactions in bone marrow transplantation. In: European Journal of Immunology. 2010 ; Vol. 40, No. 7. pp. 1862-1869.
@article{f238b7b8e5244f5996ee42f3ce8c13e8,
title = "NKT cells, Treg, and their interactions in bone marrow transplantation",
abstract = "Bone marrow transplantation (BMT) is a potentially curative treatment for patients with leukemia and lymphoma. Tumor eradication is promoted by the anti-tumor activity of donor T cells contained in the transplant; however, donor T cells also mediate the serious side effect of graft-versus-host disease (GVHD). Separation of GVHD from graft anti-tumor activity is an important goal of research in improving transplant outcome. One approach is to take advantage of the immunomodulatory activity of regulatory NKT cells and CD4+ CD25+ Treg of host and/or donor origin. Both host and donor NKT cells and donor Treg are able to prevent GVHD in murine models. In this review, we summarize the mechanisms of NKT cell- and Treg-mediated protection against GVHD in mice while maintaining graft anti-tumor activity. In addition, we also examine the interactions between NKT cells and Treg in the context of BMT, and integrate the data from murine experimental models with the observations made in humans.",
keywords = "Bone marrow transplantation, Natural killer T cells, Regulatory T cells",
author = "Kohrt, {Holbrook E.} and Asha Pillai and Robert Lowsky and Samuel Strober",
year = "2010",
month = "1",
day = "1",
doi = "10.1002/eji.201040394",
language = "English (US)",
volume = "40",
pages = "1862--1869",
journal = "European Journal of Immunology",
issn = "0014-2980",
publisher = "Wiley-VCH Verlag",
number = "7",

}

TY - JOUR

T1 - NKT cells, Treg, and their interactions in bone marrow transplantation

AU - Kohrt, Holbrook E.

AU - Pillai, Asha

AU - Lowsky, Robert

AU - Strober, Samuel

PY - 2010/1/1

Y1 - 2010/1/1

N2 - Bone marrow transplantation (BMT) is a potentially curative treatment for patients with leukemia and lymphoma. Tumor eradication is promoted by the anti-tumor activity of donor T cells contained in the transplant; however, donor T cells also mediate the serious side effect of graft-versus-host disease (GVHD). Separation of GVHD from graft anti-tumor activity is an important goal of research in improving transplant outcome. One approach is to take advantage of the immunomodulatory activity of regulatory NKT cells and CD4+ CD25+ Treg of host and/or donor origin. Both host and donor NKT cells and donor Treg are able to prevent GVHD in murine models. In this review, we summarize the mechanisms of NKT cell- and Treg-mediated protection against GVHD in mice while maintaining graft anti-tumor activity. In addition, we also examine the interactions between NKT cells and Treg in the context of BMT, and integrate the data from murine experimental models with the observations made in humans.

AB - Bone marrow transplantation (BMT) is a potentially curative treatment for patients with leukemia and lymphoma. Tumor eradication is promoted by the anti-tumor activity of donor T cells contained in the transplant; however, donor T cells also mediate the serious side effect of graft-versus-host disease (GVHD). Separation of GVHD from graft anti-tumor activity is an important goal of research in improving transplant outcome. One approach is to take advantage of the immunomodulatory activity of regulatory NKT cells and CD4+ CD25+ Treg of host and/or donor origin. Both host and donor NKT cells and donor Treg are able to prevent GVHD in murine models. In this review, we summarize the mechanisms of NKT cell- and Treg-mediated protection against GVHD in mice while maintaining graft anti-tumor activity. In addition, we also examine the interactions between NKT cells and Treg in the context of BMT, and integrate the data from murine experimental models with the observations made in humans.

KW - Bone marrow transplantation

KW - Natural killer T cells

KW - Regulatory T cells

UR - http://www.scopus.com/inward/record.url?scp=77954104148&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=77954104148&partnerID=8YFLogxK

U2 - 10.1002/eji.201040394

DO - 10.1002/eji.201040394

M3 - Review article

C2 - 20583031

AN - SCOPUS:77954104148

VL - 40

SP - 1862

EP - 1869

JO - European Journal of Immunology

JF - European Journal of Immunology

SN - 0014-2980

IS - 7

ER -